Literature DB >> 11483320

Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy.

F M Buffa1, S E Davidson, R D Hunter, A E Nahum, C M West.   

Abstract

PURPOSE: To assess whether incorporation of measurements of surviving fraction at 2 Gy (SF(2)) and colony-forming efficiency (CFE) into a tumor control probability (tcp) model increases their prognostic significance. METHODS AND MATERIALS: Measurements of SF(2) and CFE were available from a study on carcinoma of the cervix treated with radiation alone. These measurements, as well as tumor volume, dose, and treatment time, were incorporated into a Poisson tcp model (tcp(alpha,rho)). Regression analysis was performed to assess the prognostic power of tcp(alpha,rho) vs. the use of either tcp models with biologic parameters fixed to best-fit estimates (but incorporating individual dose, volume, and treatment time) or the use of SF(2) and CFE measurements alone.
RESULTS: In a univariate regression analysis of 44 patients, tcp(alpha,rho) was a better prognostic factor for both local control and survival (p < 0.001 and p = 0.049, respectively) than SF(2) alone (p = 0.009 for local control, p = 0.29 for survival) or CFE alone (p = 0.015 for local control, p = 0.38 for survival). In multivariate analysis, tcp(alpha,rho) emerged as the most important prognostic factor for local control (p < 0.001, relative risk of 2.81). After allowing for tcp(alpha,rho), CFE was still a significant independent prognostic factor for local control, whereas SF(2) was not. The sensitivities of tcp(alpha,rho) and SF(2) as predictive tests for local control were 87% and 65%, respectively. Specificities were 70% and 77%, respectively.
CONCLUSIONS: A Poisson tcp model incorporating individual SF(2), CFE, dose, tumor volume, and treatment time was found to be the best independent prognostic factor for local control and survival in cervical carcinoma patients.

Entities:  

Mesh:

Year:  2001        PMID: 11483320     DOI: 10.1016/s0360-3016(01)01584-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  Radiogenomics and radiotherapy response modeling.

Authors:  Issam El Naqa; Sarah L Kerns; James Coates; Yi Luo; Corey Speers; Catharine M L West; Barry S Rosenstein; Randall K Ten Haken
Journal:  Phys Med Biol       Date:  2017-08-01       Impact factor: 3.609

2.  Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy.

Authors:  P Mavroidis; C Shi; G A Plataniotis; M G Delichas; B Costa Ferreira; S Rodriguez; B K Lind; N Papanikolaou
Journal:  Br J Radiol       Date:  2010-09-21       Impact factor: 3.039

Review 3.  External beam techniques to boost cervical cancer when brachytherapy is not an option-theories and applications.

Authors:  Omar Mahmoud; Sarah Kilic; Atif J Khan; Sushil Beriwal; William Small
Journal:  Ann Transl Med       Date:  2017-05

Review 4.  Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy.

Authors:  In Ja Park; Chang Sik Yu
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

5.  A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.

Authors:  Steven A Eschrich; Jimmy Pramana; Hongling Zhang; Haiyan Zhao; David Boulware; Ji-Hyun Lee; Gregory Bloom; Caio Rocha-Lima; Scott Kelley; Douglas P Calvin; Timothy J Yeatman; Adrian C Begg; Javier F Torres-Roca
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-10-01       Impact factor: 7.038

6.  A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy.

Authors:  Javier F Torres-Roca
Journal:  Per Med       Date:  2012-07       Impact factor: 2.512

7.  Predicting outcomes in cervical cancer: a kinetic model of tumor regression during radiation therapy.

Authors:  Zhibin Huang; Nina A Mayr; William T C Yuh; Simon S Lo; Joseph F Montebello; John C Grecula; Lanchun Lu; Kaile Li; Hualin Zhang; Nilendu Gupta; Jian Z Wang
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

Review 8.  Radiation-induced erectile dysfunction: Recent advances and future directions.

Authors:  Javed Mahmood; Aksinija A Shamah; T Michael Creed; Radmila Pavlovic; Hotaka Matsui; Masaki Kimura; Jason Molitoris; Hem Shukla; Isabel Jackson; Zeljko Vujaskovic
Journal:  Adv Radiat Oncol       Date:  2016-06-03

Review 9.  Dose Summation Strategies for External Beam Radiation Therapy and Brachytherapy in Gynecologic Malignancy: A Review from the NRG Oncology and NCTN Medical Physics Subcommittees.

Authors:  Hayeon Kim; Yongsook C Lee; Stanley H Benedict; Brandon Dyer; Michael Price; Yi Rong; Ananth Ravi; Eric Leung; Sushil Beriwal; Mark E Bernard; Jyoti Mayadev; Jessica R L Leif; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-06-17       Impact factor: 7.038

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.